Canada Health reports the facility received a “non compliant” rating and highlighted several issues with the company’s process of making health products.
WEST COLUMBIA, S.C. — Local pharmaceutical corporation Nephron was recently flagged by the Canadian Health Agency for quality control and sterilization issues of their products.
Canadian Health recently released a report calling West Columbia drug manufacturer Nephron Pharmaceuticals inadequate. This comes after inspectors from the Canadian Health Agency visited the facility in October.
In the report, Canada Health, gives the facility an overall “non compliant” rating and highlighted several issues with the company’s process of making health products.
The report examined multiple areas such as, sanitation, personnel and the sterilization of products. It states “the company did not take precautions to minimize contamination during all processing prior to sterilization.”
It also noted that the “the education, experience and/or oversight of the individual in charge of the manufacturing department was inadequate.”
In response to the report, Nephron said in a statement to News …